Ozaki M - Search Results

1

Studies on pyridonecarboxylic acids. 1. Synthesis and antibacterial evaluation of 7-substituted-6-halo-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3- carboxylic acids.

Segawa J, Kitano M, Kazuno K, Matsuoka M, Shirahase I, Ozaki M, Matsuda M, Tomii Y, Kise M. Segawa J, et al. Among authors: ozaki m. J Med Chem. 1992 Dec 11;35(25):4727-38. doi: 10.1021/jm00103a011. J Med Chem. 1992. PMID: 1335082

2

In vitro antibacterial activity of a new quinolone, NM394.

Ozaki M, Matsuda M, Tomii Y, Kimura K, Kazuno K, Kitano M, Kise M, Shibata K, Otsuki M, Nishino T. Ozaki M, et al. Antimicrob Agents Chemother. 1991 Dec;35(12):2490-5. doi: 10.1128/AAC.35.12.2490. Antimicrob Agents Chemother. 1991. PMID: 1667251 Free PMC article.

3

In vivo evaluation of NM441, a new thiazeto-quinoline derivative.

Ozaki M, Matsuda M, Tomii Y, Kimura K, Segawa J, Kitano M, Kise M, Shibata K, Otsuki M, Nishino T. Ozaki M, et al. Antimicrob Agents Chemother. 1991 Dec;35(12):2496-9. doi: 10.1128/AAC.35.12.2496. Antimicrob Agents Chemother. 1991. PMID: 1667252 Free PMC article.

4

Studies on pyridonecarboxylic acids. IV. Synthesis and antibacterial activity evaluation of S-(-)- and R-(+)-6-fluoro-1-methyl-4-oxo-7- (1-piperazinyl)-4H-[1,3] thiazeto[3,2-a]quinoline-3-carboxylic acids.

Segawa J, Kazuno K, Matsuoka M, Amimoto I, Ozaki M, Matsuda M, Tomii Y, Kitano M, Kise M. Segawa J, et al. Among authors: ozaki m. Chem Pharm Bull (Tokyo). 1995 Jul;43(7):1238-40. doi: 10.1248/cpb.43.1238. Chem Pharm Bull (Tokyo). 1995. PMID: 7586065

5

Studies on pyridonecarboxylic acids. III. Synthesis and antibacterial activity evaluation of 1,8-disubstituted 6-fluoro-4-oxo-7-piperazinyl-4H-[1,3]thiazeto[3,2- a]quinoline-3-carboxylic acid derivatives.

Segawa J, Kazuno K, Matsuoka M, Shirahase I, Ozaki M, Matsuda M, Tomii Y, Kitano M, Kise M. Segawa J, et al. Among authors: ozaki m. Chem Pharm Bull (Tokyo). 1995 Jan;43(1):63-70. doi: 10.1248/cpb.43.63. Chem Pharm Bull (Tokyo). 1995. PMID: 7895308

6

Uptake and intracellular activity of NM394, a new quinolone, in human polymorphonuclear leukocytes.

Ozaki M, Komori K, Matsuda M, Yamaguchi R, Honmura T, Tomii Y, Nishimura I, Nishino T. Ozaki M, et al. Antimicrob Agents Chemother. 1996 Mar;40(3):739-42. doi: 10.1128/AAC.40.3.739. Antimicrob Agents Chemother. 1996. PMID: 8851603 Free PMC article.

7

Structure-antibacterial activity and cytotoxicity relationships of thiazolo and thiazetoquinolone derivatives.

Ozaki M, Segawa J, Kitano M, Tomii Y, Honmura T, Matsuda M, Kise M, Nishino T. Ozaki M, et al. Biol Pharm Bull. 1996 Nov;19(11):1457-62. doi: 10.1248/bpb.19.1457. Biol Pharm Bull. 1996. PMID: 8951164 Free article.

8

Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.

Tomii Y, Ozaki M, Matsuda M, Honmura T, Nishimura I, Yamaguchi R, Adachi T, Okawa Y, Nishino T. Tomii Y, et al. Among authors: ozaki m. Arzneimittelforschung. 1996 Dec;46(12):1169-73. Arzneimittelforschung. 1996. PMID: 9006794

9

In vivo antibacterial activity of a prodrug of NM394, a thiazetoquinoline carboxylic acid derivative.

Ozaki M, Tomii Y, Matsuda M, Segawa J, Kitano M, Kise M, Nishino T. Ozaki M, et al. Chemotherapy. 1998 Jan-Feb;44(1):21-30. doi: 10.1159/000007086. Chemotherapy. 1998. PMID: 9444405

10

Antitumor activity of acylated oridonin.

Fujita E, Nagao Y, Kohno T, Matsuda M, Ozaki M. Fujita E, et al. Among authors: ozaki m. Chem Pharm Bull (Tokyo). 1981 Nov;29(11):3208-13. doi: 10.1248/cpb.29.3208. Chem Pharm Bull (Tokyo). 1981. PMID: 7337928 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,681 results

Search Page

Filters